Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

LUCD

Lucid Diagnostics (LUCD)

Lucid Diagnostics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:LUCD
DateTimeSourceHeadlineSymbolCompany
10/31/20248:31AMPR Newswire (US)PAVmed to Hold a Business Update Conference Call and Webcast on November 14, 2024NASDAQ:LUCDLucid Diagnostics Inc
10/30/20248:31AMPR Newswire (US)Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 13, 2024NASDAQ:LUCDLucid Diagnostics Inc
10/15/20247:51AMPR Newswire (US)Lucid Diagnostics Receives Notice of Allowance for Key Patent Underlying Its EsoGuard Esophageal DNA TestNASDAQ:LUCDLucid Diagnostics Inc
10/09/20248:01AMPR Newswire (US)Lucid Diagnostics to Participate in the 2024 Maxim Healthcare Virtual SummitNASDAQ:LUCDLucid Diagnostics Inc
10/08/20247:49AMPR Newswire (US)Lucid Diagnostics to Join Global Medtech Leaders at The MedTech Conference 2024NASDAQ:LUCDLucid Diagnostics Inc
10/01/20248:01AMPR Newswire (US)Lucid Diagnostics Holds Inaugural #CheckYourFoodTube Precancer Testing Event for Former NFL PlayersNASDAQ:LUCDLucid Diagnostics Inc
09/24/20248:01AMPR Newswire (US)American Foregut Society's 2024 Annual Meeting to Highlight Lucid Diagnostics' EsoGuard Esophageal Precancer TestNASDAQ:LUCDLucid Diagnostics Inc
09/16/20244:30PMPR Newswire (US)PAVmed Announces Efforts to Regain Compliance with Nasdaq Listing RequirementsNASDAQ:LUCDLucid Diagnostics Inc
09/10/20247:56AMPR Newswire (US)Lucid Diagnostics to Host Symposium on Non-Endoscopic Esophageal Precancer Screening at the 20th International Society for Diseases of the Esophagus (ISDE) World CongressNASDAQ:LUCDLucid Diagnostics Inc
09/03/20247:51AMPR Newswire (US)Lucid Diagnostics Signs Memorandum of Understanding with Front Line Mobile HealthNASDAQ:LUCDLucid Diagnostics Inc
08/20/20248:16AMPR Newswire (US)Lucid Diagnostics Announces Publication of Analytical Validation Study of EsoGuard® for Early Detection of Esophageal Precancer and CancerNASDAQ:LUCDLucid Diagnostics Inc
08/13/20248:16AMPR Newswire (US)The American Foregut Society Formally Requests Medical Policy Coverage of EsoGuard® to Enhance Early Detection of Esophageal CancerNASDAQ:LUCDLucid Diagnostics Inc
08/13/20248:01AMPR Newswire (US)PAVmed Provides Business Update and Second Quarter 2024 Financial ResultsNASDAQ:LUCDLucid Diagnostics Inc
08/12/20248:31AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LUCDLucid Diagnostics Inc
08/12/20248:15AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LUCDLucid Diagnostics Inc
08/12/20248:07AMPR Newswire (US)Lucid Diagnostics Provides Business Update and Second Quarter 2024 Financial ResultsNASDAQ:LUCDLucid Diagnostics Inc
08/08/20248:31AMPR Newswire (US)Lucid Diagnostics Holds First Major Directly-Contracted EsoGuard® #CheckYourFoodTube Precancer Testing EventNASDAQ:LUCDLucid Diagnostics Inc
08/06/20248:15AMPR Newswire (US)Lucid Diagnostics Announces Positive Data from ENVET-BE Clinical Utility Study of EsoGuard® Esophageal Precancer TestingNASDAQ:LUCDLucid Diagnostics Inc
08/05/20248:15AMPR Newswire (US)Lucid Diagnostics to Participate in Upcoming Investor ConferencesNASDAQ:LUCDLucid Diagnostics Inc
07/30/20248:15AMPR Newswire (US)PAVmed to Hold a Business Update Conference Call and Webcast on August 13, 2024NASDAQ:LUCDLucid Diagnostics Inc
07/29/20248:15AMPR Newswire (US)Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on August 12, 2024NASDAQ:LUCDLucid Diagnostics Inc
07/23/20248:01AMPR Newswire (US)Lucid Diagnostics Announces Record Quarterly EsoGuard® Test VolumeNASDAQ:LUCDLucid Diagnostics Inc
07/19/20249:00AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:LUCDLucid Diagnostics Inc
07/19/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:LUCDLucid Diagnostics Inc
07/12/20244:30PMEdgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:LUCDLucid Diagnostics Inc
07/11/20248:31AMPR Newswire (US)Lucid Diagnostics Launches New Corporate WebsiteNASDAQ:LUCDLucid Diagnostics Inc
07/02/20247:55AMPR Newswire (US)Lucid Diagnostics Announces Positive Data from its ESOGUARD BE-1 Prospective, International, Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing in a Screening PopulationNASDAQ:LUCDLucid Diagnostics Inc
06/12/20248:05AMPR Newswire (US)4,000th Firefighter Undergoes Lucid Diagnostics' EsoGuard® Esophageal Precancer TestingNASDAQ:LUCDLucid Diagnostics Inc
06/06/20249:48AMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:LUCDLucid Diagnostics Inc
06/06/20248:40AMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:LUCDLucid Diagnostics Inc
 Showing the most relevant articles for your search:NASDAQ:LUCD